Results

Total Results: 537 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

181. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … As with all of its recommendations, the USPSTF encourages clinicians to discuss with patients the risks … PDQ Breast Cancer Prevention (PDQ®)—Patient Version. NCI website. … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. … Safety assessment of raloxifene over eight years in a clinical trial setting.

182. Archived: Evidence Summary: Blood Pressure in Children and Adolescents (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary16/blood-pressure-in-children-and-adolescents-hypertension-screening-october-2013
     February 15, 2013 - Another study reported a case of near syncope and an elevated creatinine in a patient who received an … placebo groups (0.76 per patient) after 2 to 4 weeks of follow-up (between-group  P  = 0.37). … Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. … taking drug treatments and 11% to 48% in patients taking placebo. … : 41.9% Low dose patients: 41.7% Placebo patients: 31.3% Significance not reported 2 patients discontinued

183. Shared Decision Making About Screening and Chemoprevention | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/shared-decision-making-about-screening-and-chemoprevention
     January 01, 2017 - style of patient interaction, but does have suggestions for clinicians on how to interact with patients … to patients. … Physicians and patients: a history of silence.  The Silent World of Doctor and Patient . … Impact of patient activation intervention in diabetic patients.  Diabetes Care  1991;14:881-9. … Using statistical risk information to assess oral contraceptive safety. 

184. Shared Decision Making About Screening and Chemoprevention | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/shared-decision-making-about-screening-and-chemoprevention
     January 01, 2017 - style of patient interaction, but does have suggestions for clinicians on how to interact with patients … to patients. … Physicians and patients: a history of silence.  The Silent World of Doctor and Patient . … Impact of patient activation intervention in diabetic patients.  Diabetes Care  1991;14:881-9. … Using statistical risk information to assess oral contraceptive safety. 

185. Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k-btyK4W2-v9KnemTK8WDx
     September 14, 2021 - Editorial page 913 Multimedia Related article page 949 and JAMA Patient Page page 984 Supplemental … Data Abstraction and Quality Rating A single investigator abstracted details about study design, patient … key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … A cross-sectional study of a 3-item (age, indicators of risk, and injection drug use) risk score (n … These results were largely based on asymptomatic patient populations, increasing relevance to screen

186. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9H5mgkBCjNQVZZ4pnkNo6B
     February 01, 2016 - Synthesis: Limited evidence from 5 studies showed that such tools as the Beck Depression Inventory and Patient … These 5 studies ex- amined such instruments as the Patient Health Ques- tionnaire for Adolescents, Beck … In summary, the Patient Health Questionnaire for Adolescents and BDI reported the highest sensitivity … The patients eligible for these trials may not be representative of all patients with MDD seen in primary … serotonin reuptake inhibitors in pediatric depression: did unpublished studies influence the efficacy/safety

187. Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KYaqKCUyn2rjUGfoS977h8
     July 10, 2023 - . doi:10.1001/jama.2023.9865 Editorial page 699 Multimedia Related article page 736 and JAMA Patient … Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … What is the diagnostic accuracy of provider or patient risk assessment tools in identifying persons … All adverse events were grade 1 except in 1 patient with grade 2 symptoms. … AIDS Patient Care STDS. 2021;35(1):5-8. doi:10.1089/apc.2020.0231 58.

188. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
     May 29, 2012 - Investigators created an analytic framework incorporating the key questions and outlining the patient … Extraction and Quality Assessment From the included studies, an investigator abstracted details of the patient … The data and safety monitoring boards stopped both trials early because of increased adverse effects … provided few results applicable to clinical decisions about selecting hormone therapy based on individual patient … The patient population of interest is postmenopausal women.

189. Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - assessing the risk for preeclampsia and discuss the benefits and harms of low-dose aspirin use with their patients … Implementation Risk factors, based on medical history, may help guide clinicians and their patients … In October 2020, the US Food and Drug Administration released a safety drug communication warning that … Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … FDA Drug Safety Communication: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later

190. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
     March 01, 2007 - existed, such as the methods and timing of ascertainment of exposure (for example, questionnaires, patient … records, and databases) and out- come (for example, colonoscopy, patient records, and da- tabases). … Celecoxib Valde- coxib Cardiovascular Safety. … 1996 (31) United States 113/226 2.5 y First colonoscopic diagnosis of colorectal adenoma Hospital patient … NSAIDs (questionnaire) Poor Peleg et al., 1996 (31) United States 93/186 5.5 y Incident CRC Hospital patient

191. Recommendation: Skin Cancer Prevention: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-counseling
     March 20, 2018 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Potential Harms Skin self-examination is performed by the patient and is noninvasive. … tanning. 10 The Environmental Protection Agency provides a variety of educational tools regarding sun safety … It also provides sun safety fact sheets and handouts, including age-appropriate materials. 11 Useful … Sun safety. https://www.epa.gov/sunsafety . Accessed February 2, 2018.

192. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - existed, such as the methods and timing of ascertainment of exposure (for example, questionnaires, patient … records, and databases) and outcome (for example, colonoscopy, patient records, and databases). … Celecoxib Valdecoxib Cardiovascular Safety. … 113/226 2.5 y First colonoscopic diagnosis of colorectal adenoma Hospital patient … ., 1996 31 United States 93/186 5.5 y Incident CRC Hospital patient

193. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - existed, such as the methods and timing of ascertainment of exposure (for example, questionnaires, patient … records, and databases) and outcome (for example, colonoscopy, patient records, and databases). … Celecoxib Valdecoxib Cardiovascular Safety. … 113/226 2.5 y First colonoscopic diagnosis of colorectal adenoma Hospital patient … ., 1996 31 United States 93/186 5.5 y Incident CRC Hospital patient

194. Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3R9N4ojm9Sk7qk8ybD3LU6
     October 11, 2019 - Viewpoint page 1143 and Editorial page 1152 Related article page 1195 and JAMA Patient Page page 1222 … choice of antibacterial regimen for treatment of asymp- tomatic bacteriuria during pregnancy is based on safety … Both studies included patients screened at the first prenatal visit with urine culture and treated on … Patients in the control groups had higher rates of pyelonephri- tis than those in the treatment groups … , 1 study included only women with diabetes (mean age, 55 years), and 3 studies included only older patients

195. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
     June 09, 2020 - the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … quency of use, or both), (2) risk assessment (addressing the conse- quences of drug use, typically indicators … No study was conducted in adolescents, and no trial strati- fied outcomes by patient sex. … for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients … Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial

196. Recommendation: Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening
     October 23, 2018 - JAMA Patient … Clinicians should understand the evidence but individualize decision making to the specific patient or … Clinical Considerations Patient … PVS includes 3 items that assess physical abuse and safety. … Some comments asked for clarification about the patient population, including whether men and older women

197. Interventions for Weight Management in Children and Adolescents: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/e9f8a_uGMXxSbBUxpRPkrc
     June 18, 2024 - Editorial Multimedia Related article and JAMA Patient Page Supplemental content CME at jamacmelookup.com … questions that the review will address in order to allow the USPSTF to evaluate the effectiveness and safety … adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety … placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics … Impact of weight bias and stigma on quality of care and outcomes for patients with obesity.

198. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTJ_Zj3TAkhx45wWUDtNyt
     May 01, 2021 - For patients with an es- timated 10-year CVD risk of 10% or greater and who smoke or have Adults aged … agrees to take a statin.12 For patients with an estimated 10-year CVD risk of 7.5% to less than 10% … Patients in this estimated risk range who place a higher value on the potential benefits than on the … agrees. • In patients who have a cardiovascular risk factor and an estimated 10-year CVD risk of 7.5% … • The efficacy and safety of long-term statin use in adults younger than 40 years, and to determine

199. Screening for Hypertension in Children and Adolescents (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Aqm6uW6_HrTRVJ-EVCVaRV
     March 01, 2013 - ) and placebo groups (0.76 per patient) af­ ter 2 to 4 weeks of follow-up (between­ group P = .37). … Patient-, provider-, and clinic- level predictors of unrecognized elevated blood pressure in children … Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. … Safety of placebo controls in pediatric hypertension trials. … Placebo patients: 31.3% Significance not reported 2 patients discontinued due to AEs, both in the

200. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Components of adherence support include establishing trust and open communication with patients, patient … Research is also needed on the long-term safety and effectiveness of PrEP. … Methods for evaluating adherence differed between studies and included patient diaries and self-report … An HIV preexposure prophylaxis demonstration project and safety study for young MSM.